Sectra MicroDose Mammography


Key to the very high image quality at significantly reduced radiation dose, is Sectra’s revolutionary photon counting detector technology. Sectra MicroDose is the first imaging modality based on a photon counting detector technology to receive FDA clearance.

Low resolution

Medium resolution

Original resolution

About Us

Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2023/2024 fiscal year totaled SEK 2,964 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.

Subscribe

Related Releases